Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Educational endowments earned investment returns averaging -0.3% in FY2012, down sharply from 19.2% in FY2011

Friday, February 08, 2013

Bailey McCann, Opalesque New York: Educational endowments took a hit to their returns over 2012. Data gathered from 831 U.S. colleges and universities for the 2012 NACUBO-Commonfund Study of Endowments® (NCSE) show that these institutions’ endowments returned an average of -0.3%(net of fees) for the 2012 fiscal year (July 1, 2011 – June 30, 2012)—a steep decline from the FY2011 average return of 19.2%. However, over the longer term, ten-year returns for FY2012 were 6.2% compared with 5.6% in FY2011, suggesting that long-term performance for many institutions continues to improve.

The data are broken down into six categories according to size of endowment, ranging from institutions with endowment assets under $25m to those with assets in excess of $1bn. These large endowments produced the highest FY2012 return, an average of 0.8%. The other categories with positive returns were endowments with assets between $501m and $1bn, which reported an average return of 0.4%, and endowments with assets under $25m, which reported an average return of 0.3%. All three of the mid-sized cohorts reported negative returns, the lowest being-1.0 percent among institutions with assets between $51 and $100m. Institutions with assets between $101 and $500m returned -0.7%, while those with assets between $25 and $50m returned -0.5%.

This year’s data show that institutions’ trailing three-year returns averaged 10.2%; ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its